Cargando…

The onset risk of carcinoma in patients continuing tacrolimus topical treatment for oral lichen planus: a case report

Oral lichen planus is a chronic inflammatory mucocutaneous disease. Topical use of steroids and other immuno-modulating therapies have been tried for this intractable condition. Nowadays, tacrolimus ointment is used more commonly as a choice for treatment. However, a number of discussions have taken...

Descripción completa

Detalles Bibliográficos
Autores principales: Morita, Mayu, Asoda, Seiji, Tsunoda, Kazuyuki, Soma, Tomoya, Nakagawa, Taneaki, Shirakawa, Masayori, Shoji, Hirofumi, Yagishita, Hisao, Nishikawa, Takeji, Kawana, Hiromasa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352802/
https://www.ncbi.nlm.nih.gov/pubmed/27368962
http://dx.doi.org/10.1007/s10266-016-0255-4
_version_ 1782515026167332864
author Morita, Mayu
Asoda, Seiji
Tsunoda, Kazuyuki
Soma, Tomoya
Nakagawa, Taneaki
Shirakawa, Masayori
Shoji, Hirofumi
Yagishita, Hisao
Nishikawa, Takeji
Kawana, Hiromasa
author_facet Morita, Mayu
Asoda, Seiji
Tsunoda, Kazuyuki
Soma, Tomoya
Nakagawa, Taneaki
Shirakawa, Masayori
Shoji, Hirofumi
Yagishita, Hisao
Nishikawa, Takeji
Kawana, Hiromasa
author_sort Morita, Mayu
collection PubMed
description Oral lichen planus is a chronic inflammatory mucocutaneous disease. Topical use of steroids and other immuno-modulating therapies have been tried for this intractable condition. Nowadays, tacrolimus ointment is used more commonly as a choice for treatment. However, a number of discussions have taken place after tacrolimus was reported to be carcinogenic. This report describes a patient who applied tacrolimus ointment to the lower lip after being diagnosed with oral lichen planus in 2008, and whose lesion developed squamous cell carcinoma in 2010. Since the relationship between tacrolimus and cancer development has been reported in only a few cases, including this case report, the clinician must be careful selecting tacrolimus as a second-line treatment for oral lichen planus.
format Online
Article
Text
id pubmed-5352802
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer Japan
record_format MEDLINE/PubMed
spelling pubmed-53528022017-03-28 The onset risk of carcinoma in patients continuing tacrolimus topical treatment for oral lichen planus: a case report Morita, Mayu Asoda, Seiji Tsunoda, Kazuyuki Soma, Tomoya Nakagawa, Taneaki Shirakawa, Masayori Shoji, Hirofumi Yagishita, Hisao Nishikawa, Takeji Kawana, Hiromasa Odontology Case Report Oral lichen planus is a chronic inflammatory mucocutaneous disease. Topical use of steroids and other immuno-modulating therapies have been tried for this intractable condition. Nowadays, tacrolimus ointment is used more commonly as a choice for treatment. However, a number of discussions have taken place after tacrolimus was reported to be carcinogenic. This report describes a patient who applied tacrolimus ointment to the lower lip after being diagnosed with oral lichen planus in 2008, and whose lesion developed squamous cell carcinoma in 2010. Since the relationship between tacrolimus and cancer development has been reported in only a few cases, including this case report, the clinician must be careful selecting tacrolimus as a second-line treatment for oral lichen planus. Springer Japan 2016-07-01 2017 /pmc/articles/PMC5352802/ /pubmed/27368962 http://dx.doi.org/10.1007/s10266-016-0255-4 Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Case Report
Morita, Mayu
Asoda, Seiji
Tsunoda, Kazuyuki
Soma, Tomoya
Nakagawa, Taneaki
Shirakawa, Masayori
Shoji, Hirofumi
Yagishita, Hisao
Nishikawa, Takeji
Kawana, Hiromasa
The onset risk of carcinoma in patients continuing tacrolimus topical treatment for oral lichen planus: a case report
title The onset risk of carcinoma in patients continuing tacrolimus topical treatment for oral lichen planus: a case report
title_full The onset risk of carcinoma in patients continuing tacrolimus topical treatment for oral lichen planus: a case report
title_fullStr The onset risk of carcinoma in patients continuing tacrolimus topical treatment for oral lichen planus: a case report
title_full_unstemmed The onset risk of carcinoma in patients continuing tacrolimus topical treatment for oral lichen planus: a case report
title_short The onset risk of carcinoma in patients continuing tacrolimus topical treatment for oral lichen planus: a case report
title_sort onset risk of carcinoma in patients continuing tacrolimus topical treatment for oral lichen planus: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352802/
https://www.ncbi.nlm.nih.gov/pubmed/27368962
http://dx.doi.org/10.1007/s10266-016-0255-4
work_keys_str_mv AT moritamayu theonsetriskofcarcinomainpatientscontinuingtacrolimustopicaltreatmentfororallichenplanusacasereport
AT asodaseiji theonsetriskofcarcinomainpatientscontinuingtacrolimustopicaltreatmentfororallichenplanusacasereport
AT tsunodakazuyuki theonsetriskofcarcinomainpatientscontinuingtacrolimustopicaltreatmentfororallichenplanusacasereport
AT somatomoya theonsetriskofcarcinomainpatientscontinuingtacrolimustopicaltreatmentfororallichenplanusacasereport
AT nakagawataneaki theonsetriskofcarcinomainpatientscontinuingtacrolimustopicaltreatmentfororallichenplanusacasereport
AT shirakawamasayori theonsetriskofcarcinomainpatientscontinuingtacrolimustopicaltreatmentfororallichenplanusacasereport
AT shojihirofumi theonsetriskofcarcinomainpatientscontinuingtacrolimustopicaltreatmentfororallichenplanusacasereport
AT yagishitahisao theonsetriskofcarcinomainpatientscontinuingtacrolimustopicaltreatmentfororallichenplanusacasereport
AT nishikawatakeji theonsetriskofcarcinomainpatientscontinuingtacrolimustopicaltreatmentfororallichenplanusacasereport
AT kawanahiromasa theonsetriskofcarcinomainpatientscontinuingtacrolimustopicaltreatmentfororallichenplanusacasereport
AT moritamayu onsetriskofcarcinomainpatientscontinuingtacrolimustopicaltreatmentfororallichenplanusacasereport
AT asodaseiji onsetriskofcarcinomainpatientscontinuingtacrolimustopicaltreatmentfororallichenplanusacasereport
AT tsunodakazuyuki onsetriskofcarcinomainpatientscontinuingtacrolimustopicaltreatmentfororallichenplanusacasereport
AT somatomoya onsetriskofcarcinomainpatientscontinuingtacrolimustopicaltreatmentfororallichenplanusacasereport
AT nakagawataneaki onsetriskofcarcinomainpatientscontinuingtacrolimustopicaltreatmentfororallichenplanusacasereport
AT shirakawamasayori onsetriskofcarcinomainpatientscontinuingtacrolimustopicaltreatmentfororallichenplanusacasereport
AT shojihirofumi onsetriskofcarcinomainpatientscontinuingtacrolimustopicaltreatmentfororallichenplanusacasereport
AT yagishitahisao onsetriskofcarcinomainpatientscontinuingtacrolimustopicaltreatmentfororallichenplanusacasereport
AT nishikawatakeji onsetriskofcarcinomainpatientscontinuingtacrolimustopicaltreatmentfororallichenplanusacasereport
AT kawanahiromasa onsetriskofcarcinomainpatientscontinuingtacrolimustopicaltreatmentfororallichenplanusacasereport